Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics

Int J Tuberc Lung Dis. 2016 Mar;20(3):402-10. doi: 10.5588/ijtld.15.0500.

Abstract

Background: Unsupervised learning technique allows researchers to identify different phenotypes of diseases with complex manifestations.

Objectives: To identify bronchiectasis phenotypes and characterise their clinical manifestations and prognosis.

Methods: We conducted hierarchical cluster analysis to identify clusters that best distinguished clinical characteristics of bronchiectasis. Demographics, lung function, sputum bacteriology, aetiology, radiology, disease severity, quality-of-life, cough scale and capsaicin sensitivity, exercise tolerance, health care use and frequency of exacerbations were compared.

Results: Data from 148 adults with stable bronchiectasis were analysed. Four clusters were identified. Cluster 1 (n = 69) consisted of the youngest patients with predominantly mild and idiopathic bronchiectasis with minor health care resource use. Patients in cluster 2 (n = 22), in which post-infectious bronchiectasis predominated, had the longest duration of symptoms, greater disease severity, poorer lung function, airway Pseudomonas aeruginosa colonisation and frequent health care resource use. Cluster 3 (n = 16) consisted of elderly patients with shorter duration of symptoms and mostly idiopathic bronchiectasis, and predominantly severe bronchiectasis. Cluster 4 (n = 41) constituted the most elderly patients with moderate disease severity. Clusters 2 and 3 tended to have a greater risk of bronchiectasis exacerbations (P = 0.06) than clusters 1 and 4.

Conclusion: Identification of distinct phenotypes will lead to greater insight into the characteristics and prognosis of bronchiectasis.

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Body Mass Index
  • Bronchiectasis / diagnosis*
  • Bronchiectasis / drug therapy
  • Bronchiectasis / genetics*
  • Cluster Analysis
  • Cohort Studies
  • Cough
  • Female
  • Follow-Up Studies
  • Forced Expiratory Volume
  • Humans
  • Male
  • Middle Aged
  • Phenotype
  • Prospective Studies
  • Pseudomonas aeruginosa / isolation & purification
  • Quality of Life
  • Risk Factors
  • Sputum / microbiology
  • Unsupervised Machine Learning*

Substances

  • Anti-Bacterial Agents